Baumal Caroline 4

What Happened Caroline Baumal, Chief Medical Officer of Apellis Pharmaceuticals (APLS), reported a disposition by gift of 900 shares of common stock on April 29, 2026. The Form 4 records the transaction as a "G" (gift) at $0.00 per share, resulting in no sale proceeds. Footnote F1 specifies this was a charitable contribution.

Key Details

• Transaction date and price: April 29, 2026 — 900 shares disposed at $0.00 per share (gift).
• Reported filing date: May 1, 2026 (filed within the typical two-business-day Form 4 window).
• Shares owned after the transaction: Not specified in the provided filing data.
• Footnotes: F1 = charitable contribution of shares; F2 notes the amount includes 898 shares from an April 30, 2026 ESPP purchase (as stated in the filing).
• Transaction code: G = Gift (disposition).

Context Gifts are disposals and generally do not signal insider confidence or a change in outlook the way purchases might; they are often for charitable, estate-planning, or personal reasons. The filing does not indicate any late reporting or other flags, and no 10%‑owner issues are noted in the provided information.